- Home
- FND vs LEGN Comparison
FND vs LEGN Comparison
Compare FND & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FND | LEGN |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | 13723 | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.9B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FND | LEGN |
|---|---|---|
| Price | $47.66 | $17.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 12 |
| Target Price | ★ $73.44 | $61.33 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.05 | N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $4,684,088,000.00 | N/A |
| Revenue This Year | $7.53 | $42.68 |
| Revenue Next Year | $7.68 | $30.52 |
| P/E Ratio | $37.66 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $42.64 | $16.24 |
| 52 Week High | $92.41 | $37.50 |
Technical Indicators
Market Signals| Indicator | FND | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 33.03 |
| Support Level | $46.29 | $16.47 |
| Resistance Level | $53.19 | $21.99 |
| Average True Range (ATR) | 1.83 | 0.89 |
| MACD | -0.14 | -0.31 |
| Stochastic Oscillator | 24.40 | 11.95 |
Price Performance
Historical ComparisonAbout FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.